-
1
-
-
0033253860
-
Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID mice
-
Ahmad, I., Masters, M.R., Schupsky, J.J., Nguyen, J., Ali, S., Janoff, A.S., Mayhew, E., 1999. Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID mice. Oncol. Res. 11, 273-280.
-
(1999)
Oncol. Res.
, vol.11
, pp. 273-280
-
-
Ahmad, I.1
Masters, M.R.2
Schupsky, J.J.3
Nguyen, J.4
Ali, S.5
Janoff, A.S.6
Mayhew, E.7
-
2
-
-
0037023931
-
Measuring the pH environment of DNA delivered using nonverbal vectors: Implications for lysosomal traffickin
-
Akinc, A., Langer, R., 2002. Measuring the pH environment of DNA delivered using nonverbal vectors: implications for lysosomal traffickin. Biotechnol. Bioeng. 78, 503-508.
-
(2002)
Biotechnol. Bioeng.
, vol.78
, pp. 503-508
-
-
Akinc, A.1
Langer, R.2
-
3
-
-
0028280464
-
A mixed micellar formulation suitable for potential administration of taxol
-
Alkan-Onyuksel, H., Ramakrishnan, S., Chai, H.B., Pezzuto, J.M., 1994. A mixed micellar formulation suitable for potential administration of taxol. Pharm. Res. 11, 206-212.
-
(1994)
Pharm. Res.
, vol.11
, pp. 206-212
-
-
Alkan-Onyuksel, H.1
Ramakrishnan, S.2
Chai, H.B.3
Pezzuto, J.M.4
-
4
-
-
0025731906
-
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
-
Allen, T.M., Hansen, C., Martin, F., Redemann, C., Yau-Young, A., 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066, 29-36.
-
(1991)
Biochim. Biophys. Acta.
, vol.1066
, pp. 29-36
-
-
Allen, T.M.1
Hansen, C.2
Martin, F.3
Redemann, C.4
Yau-Young, A.5
-
5
-
-
0034787765
-
Tumor targeting by covalent cojugation of a natural fatty acid to paclitaxel
-
Bradly, M.O., Webb, N.L., Anthony, F.H., Devanesan, P., Witman, P.A., Hemamalini, S., Chander, M.C., Baker, S.D., He, L., Horwitz, S.B., Swindell, C.S., 2001. Tumor targeting by covalent cojugation of a natural fatty acid to paclitaxel. Clin. Cancer Res. 7, 3229-3238.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 3229-3238
-
-
Bradly, M.O.1
Webb, N.L.2
Anthony, F.H.3
Devanesan, P.4
Witman, P.A.5
Hemamalini, S.6
Chander, M.C.7
Baker, S.D.8
He, L.9
Horwitz, S.B.10
Swindell, C.S.11
-
6
-
-
0041430798
-
Multiple injections of pegylated liposomal Doxorubicin; pharmacokinetics and therapeutic activity
-
Charrois, G.J., Allen, T.M., 2003. Multiple injections of pegylated liposomal Doxorubicin; pharmacokinetics and therapeutic activity. J. Pharmacol. Exp. Ther. 306, 1058-1067.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.306
, pp. 1058-1067
-
-
Charrois, G.J.1
Allen, T.M.2
-
7
-
-
67650860452
-
Improvement of misdistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc engrafted mouse model
-
Chow, T.H., Lin, Y.Y., Hwang, J.J., Wang, H.E., Wang, S.J., Liu, R.S., Lin, W.J., Yang, C.S., Ting, G., 2009. Improvement of misdistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc engrafted mouse model. Anticancer Res. 29, 2111-2120.
-
(2009)
Anticancer Res.
, vol.29
, pp. 2111-2120
-
-
Chow, T.H.1
Lin, Y.Y.2
Hwang, J.J.3
Wang, H.E.4
Wang, S.J.5
Liu, R.S.6
Lin, W.J.7
Yang, C.S.8
Ting, G.9
-
8
-
-
42049089314
-
Overcoming the formulation obstacles towards targeted chemotherapy: In vitro and in vivo evaluation of catatonic drug loaded immunonanoparticles
-
Debotton, N., Parnes, M., Kadouche, J., Benita, S., 2008. Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of catatonic drug loaded immunonanoparticles. J. Control. Release 127, 219-230.
-
(2008)
J. Control. Release
, vol.127
, pp. 219-230
-
-
Debotton, N.1
Parnes, M.2
Kadouche, J.3
Benita, S.4
-
9
-
-
0035253404
-
Drug-targeting strategies in cancer therapy
-
Huang, P.S., Oliff, A., 2001. Drug-targeting strategies in cancer therapy. Curr. Opin. Genet. Dev. 11, 104-110.
-
(2001)
Curr. Opin. Genet. Dev.
, vol.11
, pp. 104-110
-
-
Huang, P.S.1
Oliff, A.2
-
10
-
-
56949105019
-
Recent progress in tumor pH targeting nanotechnology
-
Lee, E.S., Gao, Z., Bae, Y.H., 2008. Recent progress in tumor pH targeting nanotechnology. J. Control. Release 132, 164-170.
-
(2008)
J. Control. Release
, vol.132
, pp. 164-170
-
-
Lee, E.S.1
Gao, Z.2
Bae, Y.H.3
-
11
-
-
0028055226
-
Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes
-
Litzinger, D.C., Builting, A.M., Van Rooijen, N., Huang, L., 1994. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1190, 99-107.
-
(1994)
Biochim. Biophys. Acta
, vol.1190
, pp. 99-107
-
-
Litzinger, D.C.1
Builting, A.M.2
Van Rooijen, N.3
Huang, L.4
-
12
-
-
0033043410
-
Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells
-
Lopes de Menezes, D.E., Kirchmeier, M.J., Gagne, J.-F., Pilarski, L.M., Allen, T.M., 1999. Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells. J. Liposome Res. 9, 199-228. (Pubitemid 29289785)
-
(1999)
Journal of Liposome Research
, vol.9
, Issue.2
, pp. 199-228
-
-
Lopes, D.M.D.E.1
Kirchmeier, M.J.2
Gagne, J.-F.3
Pilarski, L.M.4
Allen, T.M.5
-
13
-
-
0030032147
-
Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time
-
Lundberg, B.B., Mortimer, B.C., Redgrave, T.G., 1996. Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time. Int. J. Pharm. 134, 119-127.
-
(1996)
Int. J. Pharm.
, vol.134
, pp. 119-127
-
-
Lundberg, B.B.1
Mortimer, B.C.2
Redgrave, T.G.3
-
14
-
-
0031033405
-
A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol)
-
Lundberg, B.B., 1997.Asubmicron lipid emulsion coated with amphipathic polyethylene glycol for potential administration of Paclitaxel (taxol). J. Pharm. Pharmacol. 49, 16-21. (Pubitemid 27051023)
-
(1997)
Journal of Pharmacy and Pharmacology
, vol.49
, Issue.1
, pp. 16-21
-
-
Lundberg, B.B.1
-
15
-
-
0037426690
-
A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration
-
DOI 10.1016/S0168-3659(02)00323-1, PII S0168365902003231
-
Lundberg, B.B., Risovic, V., Ramaswamy, M., Wasan, K.M., 2003. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parental administration. J. Control. Release 86, 93-100. (Pubitemid 35461976)
-
(2003)
Journal of Controlled Release
, vol.86
, Issue.1
, pp. 93-100
-
-
Lundberg, B.B.1
Risovic, V.2
Ramaswamy, M.3
Wasan, K.M.4
-
16
-
-
0347996090
-
Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells
-
DOI 10.1016/j.jconrel.2003.09.016
-
Lundberg, B.B., Griffiths, G., Hansen, H.J., 2004. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells. J. Control. Release 94, 155-161. (Pubitemid 37542385)
-
(2004)
Journal of Controlled Release
, vol.94
, Issue.1
, pp. 155-161
-
-
Lundberg, B.B.1
Griffiths, G.2
Hansen, H.J.3
-
17
-
-
0035805277
-
pH-responsive polymer micro spheres: Rapid release of encapsulated material within the range of intracellular pH
-
Lynn, D.M., Amiji, M.M., Langer, R., 2001. pH-responsive polymer micro spheres: rapid release of encapsulated material within the range of intracellular pH. Angew. Chem. Int. Ed. Engl. 40, 1707-1710.
-
(2001)
Angew. Chem. Int. Ed. Engl.
, vol.40
, pp. 1707-1710
-
-
Lynn, D.M.1
Amiji, M.M.2
Langer, R.3
-
18
-
-
0034000453
-
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
-
DOI 10.1016/S0168-3659(99)00248-5, PII S0168365999002485
-
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics; a review. J. Control. Release 65 (1-2), 271-284. (Pubitemid 30122932)
-
(2000)
Journal of Controlled Release
, vol.65
, Issue.1-2
, pp. 271-284
-
-
Maeda, H.1
Wu, J.2
Sawa, T.3
Matsumura, Y.4
Hori, K.5
-
19
-
-
0026671099
-
Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)
-
Mauruyama, K., Yuda, T., Okamoto, A., Kojima, S., Suginaka, A., Iwatsuru, M., 1992. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta. 1128, 44-49.
-
(1992)
Biochim. Biophys. Acta.
, vol.1128
, pp. 44-49
-
-
Mauruyama, K.1
Yuda, T.2
Okamoto, A.3
Kojima, S.4
Suginaka, A.5
Iwatsuru, M.6
-
20
-
-
0026537177
-
Pharmacokinetics and ant tumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid
-
Mayhew, E., Lasic, D., Babbar, S., Martin, F.J., 1992. Pharmacokinetics and ant tumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int. J. Cancer 51, 302-309.
-
(1992)
Int. J. Cancer
, vol.51
, pp. 302-309
-
-
Mayhew, E.1
Lasic, D.2
Babbar, S.3
Martin, F.J.4
-
21
-
-
79953243649
-
Hydrophobic taxane derivatives
-
US Patent 5,580,899
-
Mayhew, E., Franklin, J.C., Bhatia, S., Harmon, P.A., Janoff, A.S., 1996. Hydrophobic taxane derivatives. US Patent 5,580,899.
-
(1996)
-
-
Mayhew, E.1
Franklin, J.C.2
Bhatia, S.3
Harmon, P.A.4
Janoff, A.S.5
-
22
-
-
69249158622
-
Hydrophobic taxane derivatives
-
U.S. Patent 6,291,690
-
Mayhew, E., Franklin, J.C., Bhatia, S., Harmon, P.A., Janoff, A.S., 2001. Hydrophobic taxane derivatives. U.S. Patent 6,291,690.
-
(2001)
-
-
Mayhew, E.1
Franklin, J.C.2
Bhatia, S.3
Harmon, P.A.4
Janoff, A.S.5
-
23
-
-
0033567094
-
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor
-
Monsky, W.L., Fukumura, D., Gohongi, T., Angukiewcz, M., Weich, H.A., Torchilin, V.P., Yuan, F., Jain, R.K., 1999. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59 (16), 4129-4135. (Pubitemid 29393588)
-
(1999)
Cancer Research
, vol.59
, Issue.16
, pp. 4129-4135
-
-
Monsky, W.L.1
Fukumura, D.2
Gohongi, T.3
Ancukiewcz, M.4
Weich, H.A.5
Torchilin, V.P.6
Yuan, F.7
Jain, R.K.8
-
24
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assay. J. Immunol. Methods 65, 55-63. (Pubitemid 14203433)
-
(1983)
Journal of Immunological Methods
, vol.65
, Issue.1-2
, pp. 55-63
-
-
Mosmann, T.1
-
25
-
-
3042613166
-
Sustained cytoplasm delivery of drugs with intracellular receptors using biodegradable nanoparticles
-
Panyam, J., Labhasetwar, V., 2004. Sustained cytoplasm delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm. 1, 77-84.
-
(2004)
Mol. Pharm.
, vol.1
, pp. 77-84
-
-
Panyam, J.1
Labhasetwar, V.2
-
26
-
-
77952168147
-
Targeted delivery for breast cancer therapy: The history of nanoparticle-albumin-bound paclitaxel
-
Petrelli, F., Borgonovo, K., Barni, S., 2010. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel. Expert Opin. Pharmacother. 11, 1413-1432.
-
(2010)
Expert Opin. Pharmacother.
, vol.11
, pp. 1413-1432
-
-
Petrelli, F.1
Borgonovo, K.2
Barni, S.3
-
27
-
-
0023663531
-
Mechanism and consequences of cellular cholesterol exchange and transfer
-
Phillips, M.C., Johnson, W.J., Rothblat, G.H., 1987. Mechanism and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906, 223-276.
-
(1987)
Biochim. Biophys. Acta.
, vol.906
, pp. 223-276
-
-
Phillips, M.C.1
Johnson, W.J.2
Rothblat, G.H.3
-
28
-
-
0020049344
-
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery
-
Poste, G., Bucana, C., Raz, A., Bugelski, P., Kirsh, R., Fidler, I.J., 1982. Analysis of the fate of systemically administered liposomes and implications for the use in drug delivery. Cancer Res. 42, 1412-1422. (Pubitemid 12148785)
-
(1982)
Cancer Research
, vol.42
, Issue.4
, pp. 1412-1422
-
-
Poste, G.1
Bucana, C.2
Raz, A.3
-
29
-
-
50149113005
-
Three-step tumor targeting of Paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity
-
Pulkkinen, M., Pikkarainen, J., Wirth, T., Tarvainen, T., Haapa-aho, V., Korhonen, H., Seppälä, J., Järvinen, K., 2008. Three-step tumor targeting of Paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: formulation development and in vitro anticancer activity. Eur. J. Pharm. Biopharm. 70, 66-74.
-
(2008)
Eur. J. Pharm. Biopharm.
, vol.70
, pp. 66-74
-
-
Pulkkinen, M.1
Pikkarainen, J.2
Wirth, T.3
Tarvainen, T.4
Haapa-aho, V.5
Korhonen, H.6
Seppälä, J.7
Järvinen, K.8
-
30
-
-
12244283699
-
Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery
-
DOI 10.1016/S0168-3659(02)00374-7, PII S0168365902003747
-
Potineni, A., Lynn, D.M., Langer, R., Amiji, M.M., 2003. Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for Paclitaxel delivery. J. Control. Release 86, 223-234. (Pubitemid 36084272)
-
(2003)
Journal of Controlled Release
, vol.86
, Issue.2-3
, pp. 223-234
-
-
Potineni, A.1
Lynn, D.M.2
Langer, R.3
Amiji, M.M.4
-
32
-
-
0028366109
-
Novel taxol formulations: Preparation and characterization of taxol-containing liposomes
-
Sharma, A., Sraubinger, R.M., 1994. Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm. Res. 11, 889-896.
-
(1994)
Pharm. Res.
, vol.11
, pp. 889-896
-
-
Sharma, A.1
Sraubinger, R.M.2
-
33
-
-
27144542045
-
Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations
-
DOI 10.1021/mp0500420
-
Shenoy, S., Little, S., Langer, R., Amiji, M., 2005. Poly(ethylene oxide)-modified poly (β-amino ester) nanoparticles as a ph-sensitive system for tumor-targeted delivery of hydrophobic drugs. Part I. In vitro evaluations. Mol. Pharm. 2, 357-366. (Pubitemid 41503676)
-
(2005)
Molecular Pharmaceutics
, vol.2
, Issue.5
, pp. 357-366
-
-
Shenoy, D.1
Little, S.2
Langer, R.3
Amiji, M.4
-
34
-
-
0035966497
-
Biodegradable polymeric nanoparticles as drug delivery devices
-
DOI 10.1016/S0168-3659(00)00339-4, PII S0168365900003394
-
Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1-20. (Pubitemid 32144788)
-
(2001)
Journal of Controlled Release
, vol.70
, Issue.1-2
, pp. 1-20
-
-
Soppimath, K.S.1
Aminabhavi, T.M.2
Kulkarni, A.R.3
Rudzinski, W.E.4
-
35
-
-
12244263487
-
Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies
-
Sparreboom, A., Wolff, A.C., Verweij, J., Zabelina, Y., van Zomeren, D.M., McIntire, G.L., Swindell, C.S., Donehower, R.C., Baker, S.D., 2003. Disposition of docosahexaenoic acid-paclitaxel, a novel taxane, in blood: in vitro and clinical pharmacokinetic studies. Clin. Cancer Res. 9, 151-159.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 151-159
-
-
Sparreboom, A.1
Wolff, A.C.2
Verweij, J.3
Zabelina, Y.4
Van Zomeren, D.M.5
McIntire, G.L.6
Swindell, C.S.7
Donehower, R.C.8
Baker, S.D.9
-
36
-
-
0025326680
-
Hypersensitivity reactions from taxol
-
Weiss, R.B., Donehower, R.C., Wiernik, P.H., Ohnuma, T., Gralla, R.J., Trump, D.L., Baker, J.R., Van Echo, D.A., Von Hoff, D.D., Leyland-Jones, B., 1990. Hypersensitivity reactions from taxol. J. Clin. Oncol. 8, 1263-1268.
-
(1990)
J. Clin. Oncol.
, vol.8
, pp. 1263-1268
-
-
Weiss, R.B.1
Donehower, R.C.2
Wiernik, P.H.3
Ohnuma, T.4
Gralla, R.J.5
Trump, D.L.6
Baker, J.R.7
Van Echo, D.A.8
Von Hoff, D.D.9
Leyland-Jones, B.10
-
37
-
-
12444330550
-
Phase I study of docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with unique pharmacology and toxicity profile
-
Wolff, A.C., Donehower, R.C., Carducci, M.K., Carducci, M.A., Brahmer, J.R., Zabelina, Y., Bradley, M.O., Anthony, F.H., Swindell, C.S., Witman, P.A., Webb, N.L., Baker, S.D., 2003. Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with unique pharmacology and toxicity profile. Clin. Cancer Res. 9, 3589-3597.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 3589-3597
-
-
Wolff, A.C.1
Donehower, R.C.2
Carducci, M.K.3
Carducci, M.A.4
Brahmer, J.R.5
Zabelina, Y.6
Bradley, M.O.7
Anthony, F.H.8
Swindell, C.S.9
Witman, P.A.10
Webb, N.L.11
Baker, S.D.12
|